Panbela Therapeutics Inc (PBLA)
0.41
-0.02
(-4.65%)
USD |
OTCM |
May 01, 15:58
Panbela Therapeutics Net Income (TTM): -25.25M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -25.25M |
| September 30, 2023 | -23.51M |
| June 30, 2023 | -20.08M |
| March 31, 2023 | -36.38M |
| December 31, 2022 | -34.93M |
| September 30, 2022 | -33.74M |
| June 30, 2022 | -31.48M |
| March 31, 2022 | -11.53M |
| December 31, 2021 | -10.12M |
| September 30, 2021 | -7.465M |
| June 30, 2021 | -6.994M |
| March 31, 2021 | -5.227M |
| December 31, 2020 | -4.768M |
| September 30, 2020 | -4.862M |
| June 30, 2020 | -4.565M |
| March 31, 2020 | -6.417M |
| December 31, 2019 | -6.20M |
| September 30, 2019 | -5.966M |
| June 30, 2019 | -5.517M |
| March 31, 2019 | -5.731M |
| December 31, 2018 | -5.903M |
| September 30, 2018 | -7.324M |
| June 30, 2018 | -7.618M |
| Date | Value |
|---|---|
| March 31, 2018 | -6.547M |
| December 31, 2017 | -10.37M |
| September 30, 2017 | -10.44M |
| June 30, 2017 | -10.30M |
| March 31, 2017 | -9.868M |
| December 31, 2016 | -5.119M |
| September 30, 2016 | -3.609M |
| June 30, 2016 | -3.323M |
| March 31, 2016 | -3.56M |
| December 31, 2015 | -4.927M |
| September 30, 2015 | -5.175M |
| June 30, 2015 | -5.526M |
| March 31, 2015 | -4.368M |
| December 31, 2014 | -2.288M |
| September 30, 2014 | -1.332M |
| June 30, 2014 | -0.2462M |
| March 31, 2014 | -0.2377M |
| December 31, 2013 | -0.2062M |
| September 30, 2013 | -0.0705M |
| June 30, 2013 | 0.0613M |
| March 31, 2013 | 0.2023M |
| December 31, 2012 | 0.2474M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-36.38M
Minimum
Mar 2023
-4.565M
Maximum
Jun 2020
-15.00M
Average
-7.465M
Median
Sep 2021
Net Income (TTM) Benchmarks
| Processa Pharmaceuticals Inc | -11.12M |
| Fate Therapeutics Inc | -160.93M |
| Ardelyx Inc | -66.07M |
| Checkpoint Therapeutics Inc | -51.85M |
| Palisade Bio Inc | -12.30M |